Human Leukocyte Antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission

AIDS Research and Human Retroviruses

Volumn 20, Issue 7, 2004, Pages 692-697

  Farquhar, Carey ^a   Rowland Jones, Sarah ^b   Mbori Ngacha, Dorothy ^c   Redman, Mary ^a   Lohman, Barbara ^a,c   Slyker, Jennifer ^c   Otieno, Phelgona ^d   Obimbo, Elizabeth ^b   Rostron, Timothy ^b   Ochieng, James ^c   Oyugi, Julius ^c   Bosire, Rose ^c   John Stewart, Grace ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA ANTIGEN; HLA B18 ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; BREAST FEEDING; BREAST MILK; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GENE FREQUENCY; GENETIC VARIABILITY; GESTATIONAL AGE; HAZARD ASSESSMENT; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RATE; INFECTION RISK; INTRAUTERINE INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, VERTICAL; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

EID: 3843137248     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/0889222041524616     Document Type: Article

References (29)

1. Kilpatrick DC, Hague RA, Yap PL, Mok JY: HLA antigen frequencies in children born to HIV-infected mothers. Dis Markers 1991;9:21-26.
2. Just JJ, Abrams E, Louie LG, et al.: Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1. J Pediatr 1995;127:544-549.
3. Just JJ, Louie LL, Abrams E, et al.: Genetic risk factors for perinatally acquired HIV-1 infection. Paediatr Perinat Epidemiol 1992;6:215-224.
4. Greggio NA, Cameran M, Giaquinto C, Zacchello F, Koroliuk D, and Colizzi V: DNA HLA-DRB1 analysis in children of positive mothers and estimated risk of vertical HIV transmission. Dis Markers 1993;11:21-26.
5. Winchester R, Chen Y, Rose S, Selby J, and Borkowsky W: Major histocompatibility complex class II DR alleles DRB 1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: Determination by an automated sequence-based typing method. Proc Natl Acad Sci USA 2001;92:12374-12378.
6. Polycarpou A, Ntais C, Korber BT, et al.: Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type I transmission. AIDS Res Hum Retroviruses 2002;18(11):741-746.
7. MacDonald KS, Embree JE, Nagelkerke NJ, et al.: The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 2001;183:503-506.
8. MacDonald KS, Embree J, Njenga S, et al.: Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998;177:551-556.
9. Farquhar C, VanCott TC, Mbori-Ngacha DA, et al.: Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J Infect Dis 2002;186(8):1173-1176.
10. Nduati R, John G, Mbori-Ngacha D, et al.: Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial. JAMA 2000;283(9):1167-1174.
11. Bunce M, O'Neill CM, Barnardo MC, et al.: Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-367.
12. Bird TG, Kaul R, Rostron T, et al.: HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades. AIDS 2002;16(14):1899-1904.
13. Steel CM, Ludlam CA, Beatson D, et al.: HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1988;1(8596):1185-1188.
14. Brettle RP, McNeil AJ, Burns S, et al.: Progression of HIV: Follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS 1996;10(4):419-430.
15. Kaslow RA, Duquesnoy R, VanRaden M, et al.: A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet 1990;335(8695):927-930.
16. Grene E, Pinto LA, Cohen SS, et al.: Generation of alloantigen-stimulated anti-human immunodeficiency virus activity is associated with HLA-A*02 expression. J Infect Dis 2001;183:409-416.
17. Hendel H, Caillat-Zucman S, Lebuanec H, et al.: New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999;162:6942-6946.
18. Beyrer C, Artenstein A, Rugpao S, et al.: Epidemiologic and biologic characterization of a cohort human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. J Infect Dis 1999;179:59-67.
19. Rowland-Jones SL, Dong T, Fowke KR, et al.: Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998;102(9):1758-1765.
20. Rohowsky-Kochan C, Skurnick J, Molinaro D, and Louria D: HLA antigens associated with susceptibility/resistance to HIV-1 infection. Hum Immunol 1998;59(12):802-815.
21. Carrington M, Nelson GW, Martin MP, et al.: HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-1752.
22. Panteleeff DD, John G, Nduati R, et al.: Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 1999;37(2):350-353.
23. Emery S, Bodrug S, Richardson BA, et al.: Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000;38(7):2688-2695.
24. Prentice RL, Storb R, Brown KS, and Mason MV: HLA and disease: Relative-risk regression methods and multiple testing considerations. Biometrics 1984;40(3):653-661.
25. Farewell VT and Dahlberg S: Some statistical methodology for the analysis of HLA data. Biometrics 1984;40(2):547-560.
26. MacDonald KS, Fowke KR, Kimani J, et al.: Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000;181:1581-1589.
27. Mackewicz CE, Garovoy MR, and Levy JA: HLA compatibility requirements for CD8+-T-cell-mediated suppression of human immunodeficiency virus replication. J Virol 1998;72(12):10165-10170.
28. Trinchiri G: Recognition of major histocompatibility complex class 1 antigens by natural killer cells. J Exp Med 1994;180(2):417-421.
29. Goulder PJ, Pasquier C, Holmes EC, et al.: Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNVATL epitope sequence variation. Immunol Lett 2001;79(1-2):109-116.